Advertisement
Published in:
2019 | OriginalPaper | Chapter
Options for Realising and Financing Innovation in the German Healthcare System
Authors : Bernd Baron von Maydell, Boris Baron von Maydell
Published in: Personalized Medicine in Healthcare Systems
Publisher: Springer International Publishing
Activate our intelligent search to find suitable subject content or patents.
Select sections of text to find matching patents with Artificial Intelligence. powered by
Select sections of text to find additional relevant content using AI-assisted search. powered by
Abstract
Personalised healthcare is experiencing the same difficulties as other innovations when it is introduced to the different health systems of countries. However, the high treatment costs and the complicated evaluation of the added value compared to existing methods and procedures represent particularly great challenges for personalised medicine providers and healthcare systems. In the German health care system, a large number of mechanisms have been implemented, on the one hand, to enable the fundamental introduction of innovations and, on the other hand, to permit only those innovations for standard care that bring additional benefits to the respective patients.
The first part of this article discusses the question of the prerequisites and framework conditions that help an innovation to be included in the benefits catalogue of statutory health insurance in Germany. Once this question has been successfully addressed, providers and cost bearers are faced with the difficult task of financially evaluating the new service. This is the subject of the second part.
Ultimately, a new method can only improve care if it is recognised and financed by the health systems. Against the background of increasing costs for new treatment methods, it is the task of the processes described to prevent scaling in new medical procedures.